Pathogenesis of equine herpesvirus-1 in specific pathogen-free foals: primary and secondary infections and reactivation.
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Six specific pathogen-free foals shown to be free of equine herpesvirus-1 and 4 (EHV-1 and -4) and lacking in maternally-derived antibodies were used to investigate the pathogenesis of EHV-1 in horses. Following primary intranasal inoculation with EHV-1 all foals showed signs of a mild, self-limiting upper respiratory tract infection. A leucopenia was observed, comprising both a lymphopenia and neutropenia. Virus was isolated from nasal mucus and buffy coat cells over several days during the clinical episode and after the animals became clinically normal. Notwithstanding the mildness of the clinical disease, virus was not eliminated completely and intravenous administration of dexamethasone resulted in reactivation of latent EHV-1 in animals which had received only a single dose of the virus. In a second infection given to four foals, 61 days after the primary inoculation, no clinical signs were observed, haematological changes were minimal and viraemia was absent.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Primary EHV-1 infection of several tissues of the URT results in the destruction and erosion of the epithelium and in nasal shedding starting from 1 to 14 dpi (Gibson et al., 1992; Gryspeerdt et al., 2010; Figure 1.1b).”
From The Pathogenesis and Immune Evasive Mechanisms of Equine Herpesvirus Type 1 (2021) · cites this paper as Gibson et al., 1992
In the citing paper
“Most EHV-1 infections are self-limiting in adult horses and accompanying respiratory symptoms disappear from 9 to 12 dpi (Gibson et al., 1992).”
From The Pathogenesis and Immune Evasive Mechanisms of Equine Herpesvirus Type 1 (2021) · cites this paper as Gibson et al., 1992
Citations
Cites
(1986) · PubMed · Cited by 467
Hagan and Bruner's Microbiology and Infectious Diseases of Domestic Animals
Timoney, J. F., Gillespie, J. H., Scott, F., & Barlough, J. E. (1988) · Cited by 334
Hagan and Bruner's Microbiology and Infectious Diseases of Domestic Animals
Timoney, J. F., Gillespie, J. H., Scott, F., et al. (1988) · Cited by 318
EDINGTON, N., BRIDGES, C. G., & HUCKLE, A. (1985) · Equine Veterinary Journal · doi:10.1111/j.2042-3306.1985.tb02524.x · Cited by 147 · cited 2×
“Experimental reactivation of latent EHV-1 has been shown previously [10].”
BackgroundSerological Detection of Equid Herpesvirus1 Infections of the Respiratory Tract
THOMSON, G. R., MUMFORD, J. A., CAMPBELL, J., GRIFFITHS, L., & CLAPHAM, P. (1976) · Equine Veterinary Journal · doi:10.1111/j.2042-3306.1976.tb03291.x · Cited by 122
Awan, A. R., Chong, Y.-C., & Field, H. J. (1990) · Journal of General Virology · doi:10.1099/0022-1317-71-5-1131 · Cited by 119
Self-citationTrials of an inactivated equid herpesvirus 1 vaccine: challenge with a subtype 1 virus
Burrows, R., Goodridge, D., & Denyer, M. (1984) · Veterinary Record · doi:10.1136/vr.114.15.369 · Cited by 107
On immunity to disease caused by equine herpesvirus 1.
Bryans, J. T. (1969) · PubMed · Cited by 81
(1963) · PubMed · Cited by 56
Fitzpatrick, D. R., & Studdert, M. J. (1984) · American Journal of Veterinary Research · doi:10.2460/ajvr.1984.45.10.1947 · Cited by 54 · cited 2×
“Leukopenia is a frequent finding in experimental and natural infections of non-SPF animals although neutropenia or lymphopenia alone are observed in some cases [12, 24].”
Research works printed but not linked: 5
- Erasmus BJ (1966) The activation of herpesvirus infections of the respiratory tract in horses by immunisation against horse sickness. In: Proceedings of the 1st international conference on equine infectious diseases, pp 117–121
- O'Callaghan DJ, Allen GP, Randall CC (1978) Structure and replication of equine herpesviruses. In: Proceedings of the IVth international conference on equine infectious diseases. Veterinary Publications, Princeton, pp 1–31
- Prickett ME (1969) The pathology of disease caused by equine herpesvirus-1. In: Proceedings of the 2nd international conference on equine infectious diseases, pp 24–33
- Thomson GR, Mumford JA, Plowright W (1978) Immunological responses of conventional and gnotobiotic foals to infectious and inactivated antigens of equine herpesvirus-1. In: Proceedings of the IVth international conference on equine infectious diseases. Veterinary Publications, Princeton, pp 103–114
- Wilks CR, Coggins L (1978) An assessment of lymphocyte transformation and cytotoxicity following infection with equine herpesvirus type-1. In: Proceedings of the IVth international conference on equine infectious diseases. Veterinary Publications, Princeton, pp 93–101
Cited by
Patel, J. R., & Heldens, J. (2005) · The Veterinary Journal · doi:10.1016/j.tvjl.2004.04.018 · Cited by 286
The trigeminal ganglion is a location for equine herpesvirus 1 latency and reactivation in the horse
Slater, J. D., Borchers, K., Thackray, A. M., & Field, H. J. (1994) · Journal of General Virology · doi:10.1099/0022-1317-75-8-2007 · Cited by 195
Self-citationEquine Herpesviruses 4 (Equine Rhinopneumonitis Virus) and 1 (Equine Abortion Virus)
Crabb, B. S., & Studdert, M. J. (1995) · Advances in Virus Research · doi:10.1016/s0065-3527(08)60060-3 · Cited by 180
EHV-1: A Constant Threat to the Horse Industry
Oladunni, F. S., Horohov, D. W., & Chambers, T. M. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02668 · Cited by 124
Herpesviral abortion in domestic animals
Smith, K. C. (1997) · The Veterinary Journal · doi:10.1016/s1090-0233(97)80061-5 · Cited by 130
Allen, G., Yeargan, M., Costa, L. R., & Cross, R. (1995) · Journal of Virology · doi:10.1128/jvi.69.1.606-612.1995 · Cited by 105
KYDD, J. H., SMITH, K. C., HANNANT, D., LIVESAY, G. J., & MUMFORD, J. A. (1994) · Equine Veterinary Journal · doi:10.1111/j.2042-3306.1994.tb04051.x · Cited by 93
Evaluation of orally administered valacyclovir in experimentally EHV1-infected ponies
Garré, B., Gryspeerdt, A. C., Croubels, S., Backer, J. F. A. D., & Nauwynck, H. (2008) · Veterinary Microbiology · doi:10.1016/j.vetmic.2008.09.062 · Cited by 87
Hannant, D., Jessett, D. M., O'Neill, T., Dolby, C. A., Cook, R. F., & Mumford, J. A. (1993) · Research in Veterinary Science · doi:10.1016/0034-5288(93)90126-z · Cited by 76
Vandekerckhove, A. P., Glorieux, S., Gryspeerdt, A. C., Steukers, L., Duchateau, L., Osterrieder, N., Van de Walle, G. R., & Nauwynck, H. J. (2010) · Journal of General Virology · doi:10.1099/vir.0.019257-0 · Cited by 70
“This enables the virus to reach secondary target organs where replication can cause severe symptoms such as abortion and nervous system disorders (Sabo et al., 1969; Wyler et al., 1989; Gibson et al., 1992).”
BackgroundExperimental infection with equine herpesvirus type 1 (EHV-1) induces chorioretinal lesions.
Hussey, G., Goehring, L. S., Lunn, D. P., Hussey, S. B., Huang, T., Osterrieder, N., Powell, C., Hand, J., Holz, C., & Slater, J. (2013) · Veterinary Research · doi:10.1186/1297-9716-44-118 · Cited by 70
“For experiment 1, virus shedding in nasal secretions and cell associated viremia was determined using classical plaque and infectious center assays as described previously [19].”
MethodSelf-citationFOOTE, C. E., LOVE, D. N., GILKERSON, J. R., & WHALLEY, J. M. (2004) · Equine Veterinary Journal · doi:10.2746/0425164044890634 · Cited by 70
Yang, X., Forier, K., Steukers, L., Van Vlierberghe, S., Dubruel, P., Braeckmans, K., Glorieux, S., & Nauwynck, H. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051054 · Cited by 66
“endings for spread throughout the host [4–7].”
Equine herpesvirus type 2: prevalence and seroepidemiology in foals
Murray, M. J., EICHORN, E. S., Dubovi, E. J., Ley, W. B., & Cavey, D. M. (1996) · Equine Veterinary Journal · doi:10.1111/j.2042-3306.1996.tb01614.x · Cited by 66
Glorieux, S., Broeck, W. V. D., van der Meulen, K. M., Reeth, K. V., Favoreel, H. W., & Nauwynck, H. (2007) · Journal of Virological Methods · doi:10.1016/j.jviromet.2007.01.018 · Cited by 61
Slater, J. D. (2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-2406-4.50018-1 · Cited by 81
Self-citationTewari, D., Whalley, J. M., Love, D. N., & Field, H. J. (1994) · Journal of General Virology · doi:10.1099/0022-1317-75-7-1735 · Cited by 61
Self-citationSlater, J. D., Gibson, J. S., & Field, H. J. (1993) · Journal of General Virology · doi:10.1099/0022-1317-74-5-819 · Cited by 60
Self-citationAlterations in the Equine Herpesvirus Type-1 (EHV-1) Strain RacH During Attenuation
Hübert, P. H., Birkenmaier, S., Rziha, H.-J., & Osterrieder, N. (1996) · Journal of Veterinary Medicine, Series B · doi:10.1111/j.1439-0450.1996.tb00282.x · Cited by 57
van der Meulen, K. M., Nauwynck, H. J., Buddaert, W., & Pensaert, M. B. (2000) · Microbiology · doi:10.1099/0022-1317-81-1-21 · Cited by 57
Borchers, K., Wolfinger, U., Ludwig, H., Thein, P., Baxi, S., Field, H. J., & Slater, J. D. (1998) · Virus Research · doi:10.1016/s0168-1702(98)00028-8 · Cited by 56
Self-citationThe Pathogenesis and Immune Evasive Mechanisms of Equine Herpesvirus Type 1
Laval, K., Poelaert, K. C. K., Van Cleemput, J., Zhao, J., Vandekerckhove, A. P., Gryspeerdt, A. C., Garré, B., van der Meulen, K., Baghi, H. B., Dubale, H. N., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.662686 · Cited by 54
Ambagala, A. P. N., Gopinath, R. S., & Srikumaran, S. (2004) · Journal of General Virology · doi:10.1099/vir.0.19563-0 · Cited by 53
“EHV-1 replicates in the epithelium of the upper respiratory tract, enters the peripheral circulation and disseminates systemically (Allen & Bryans, 1986; Gibson et al., 1992).”
BackgroundWalker, C. M., LOVE, D., & Whalley, J. M. (1999) · Veterinary Microbiology · doi:10.1016/s0378-1135(99)00056-5 · Cited by 60
Matsumura, T., O’Callaghan, D. J., Kondo, T., & Kamada, M. (1996) · Veterinary Microbiology · doi:10.1016/0378-1135(09)59999-3 · Cited by 51
Morley, P. S., Townsend, H. G. G., Bogdan, J. R., & Haines, D. M. (2000) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.2000.216.535 · Cited by 50
Immune escape of equine herpesvirus 1 and other herpesviruses of veterinary importance
van der Meulen, K. M., Favoreel, H. W., Pensaert, M. B., & Nauwynck, H. (2006) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2006.01.006 · Cited by 60
Dunowska, M. (2014) · New Zealand Veterinary Journal · doi:10.1080/00480169.2014.899946 · Cited by 54
Prevalence of equine herpesvirus type 1 latency detected by polymerase chain reaction
de Carvalho, R. F., Oliveira, A. M., Souza, A. M., Passos, L. M. F., & Martins, A. S. (2000) · Archives of Virology · doi:10.1007/s007050070055 · Cited by 46
“The lack of vertical transmission has been the principle by which SPF foals have been raised [13].”
BackgroundMethodBaxi, M. K., Borchers, K., Bartels, T., Schellenbach, A., Baxi, S., & Field, H. J. (1996) · Virus Research · doi:10.1016/0168-1702(95)01255-9 · Cited by 49
Self-citationGlorieux, S., Favoreel, H. W., Meesen, G., Vos, W. H. D., Broeck, W. V. D., & Nauwynck, H. (2008) · Veterinary Microbiology · doi:10.1016/j.vetmic.2008.11.005 · Cited by 42
In vitro characterisation of high and low virulence isolates of equine herpesvirus-1 and -4
Tearle, J. P., Smith, K. C., Platt, A. J., Hannant, D., Davis-Poynter, N. J., & Mumford, J. A. (2003) · Research in Veterinary Science · doi:10.1016/s0034-5288(03)00031-6 · Cited by 46
Dunowska, M. (2014) · New Zealand Veterinary Journal · doi:10.1080/00480169.2014.899945 · Cited by 44
“An initial leukopenia is followed by leukocytosis that develops approximately 1 week following EHV-1 infection, coinciding with the second peak of fever, and often with the change in character of the nasal discharge (Gibson et al. 1992a).”
BackgroundAntibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies
Soboll, G., Hussey, S. B., Whalley, J. M., Allen, G. P., Koen, M. T., Santucci, N. E., Fraser, D. G., Macklin, M. D., Swain, W. F., & Lunn, D. P. (2006) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2006.01.011 · Cited by 44
Pusterla, N., Hussey, S. B., Mapes, S., Johnson, C., Collier, J. R., Hill, J., Lunn, D. P., & Wilson, W. D. (2010) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2010.0554.x · Cited by 38
Effective Treatment of Respiratory Alphaherpesvirus Infection Using RNA Interference
Fulton, A., Peters, S., Perkins, G. A., Jarosinski, K. W., DAMIANI, A. M., Brosnahan, M. M., Buckles, E. L., Osterrieder, N., & de Walle, G. R. V. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004118 · Cited by 42
“pregnancy, competitions, and racing [3].”
Perkins, G. A., Ainsworth, D. M., Erb, H. N., Piero, F. D., Miller, M. M., Wilkins, P. A., Palmer, J. E., & Frazer, M. (1999) · Equine Veterinary Journal · doi:10.1111/j.2042-3306.1999.tb03843.x · Cited by 35
BARTELS, STEINBACH, HAHN, LUDWIG, & BORCHERS (1998) · Immunology · doi:10.1046/j.1365-2567.1998.00451.x · Cited by 35
Van Cleemput, J., Poelaert, K. C. K., Laval, K., Maes, R., Hussey, G. S., Van den Broeck, W., & Nauwynck, H. J. (2017) · Scientific Reports · doi:10.1038/s41598-017-16804-5 · Cited by 34
Reinfection and reactivation of equine herpesvirus-1 in the mouse
Field, H. J., Awan, A. R., & de la Fuente, R. (1992) · Archives of Virology · doi:10.1007/bf01317274 · Cited by 34
“Recently we have produced such reactivations in specific pathogen-free (EHV-free) foals experimentally infected with EHV-1 [17] following corticosteroid administration two or four months following primary infection with EHV-1 (AB 4).”
BackgroundSelf-citationvan der Meulen, K., Caij, B., Pensaert, M., & Nauwynck, H. (2006) · Veterinary Microbiology · doi:10.1016/j.vetmic.2005.11.048 · Cited by 32
“The respiratory mucosa may be asymptomatically reinfected as early as 2 months after previous infection (Gibson et al., 1992).”
BackgroundSeroprevalence of equine herpesvirus 1 in Thoroughbred foals before and after weaning
Gilkerson, J. R., LOVE, D., Drummer, H. E., Studdert, M. J., & Whalley, J. M. (1998) · Australian Veterinary Journal · doi:10.1111/j.1751-0813.1998.tb12282.x · Cited by 31
Josh, S., & Hannant, D. (2000) · Veterinary Clinics of North America Equine Practice · doi:10.1016/s0749-0739(17)30118-9 · Cited by 31
Tewari, D., Gibson, J. S., Slater, J. D., O'Neill, T., Hannant, D., Allen, G. P., & Field, H. J. (1993) · Archives of Virology · doi:10.1007/bf01309846 · Cited by 31
“ding of PR 1 was monophasic, whilst that of w/t EHV-1 is notably biphasic [22], and no viraemia was detected [27].”
BackgroundResultSelf-citationColle, C. F., Tarbet, E. B., Grafton, W. D., Jennings, S. R., & O’Callaghan, D. J. (1996) · Virus Research · doi:10.1016/0168-1702(96)01324-x · Cited by 31
Gibson, J. S., Slater, J. D., & Field, H. J. (1992) · Antiviral Research · doi:10.1016/0166-3542(92)90081-f · Cited by 27
Self-citationTewari, D., Nair, S. V., Ungria, M. C. A. D., Lawrence, G. L., Hayden, M., Love, D. N., Field, H. J., & Whalley, J. M. (1995) · Archives of Virology · doi:10.1007/bf01309967 · Cited by 27
“The recently developed murine model of EHV-1 pathogenesis [5, 6], however, more closely resembles the pattern of disease in the natural host [10] than the hamster models, and represents an excellent system in which to further investigate immune responses to EHV-1 or to individual components of the virus.”
BackgroundSelf-citationOns, E., Brussel, L. V., Lane, S. K., King, V. L., Cullinane, A., Kenna, R., Lyons, P., Hammond, T., Salt, J. S., & Raue, R. (2014) · Veterinary Microbiology · doi:10.1016/j.vetmic.2014.07.015 · Cited by 26
Gammaherpesvirus infections in equids: a review
Marenzoni, M. L., Stefanetti, V., Danzetta, M. L., & Timoney, P. J. (2015) · Veterinary Medicine Research and Reports · doi:10.2147/vmrr.s39473 · Cited by 23
“Latent infections can be reactivated in the absence of clinical signs, for example, after administration of high doses of corticosteroids.(26,75,79,86,87) In light of this, detection of equine γ-HV may be a consequence of reactivation of latent infection following a clinical syndrome rather than the inciting cause of…”
Primary and challenge infection of mice with equine herpesvirus 1, strain HSV25A
Walker, C. M., Packiarajah, P., Gilkerson, J. R., Love, D. N., & Whalley, J. M. (1998) · Virus Research · doi:10.1016/s0168-1702(98)00092-6 · Cited by 22
Kukreja, A., Walker, C. M., Fitzmaurice, T. J., Awan, A. R., Love, D. N., Whalley, J. M., & Field, H. J. (1998) · Veterinary Microbiology · doi:10.1016/s0378-1135(98)00211-9 · Cited by 23
Self-citationOutbreak of equid herpesvirus 1 abortions at the Arabian stud in Poland
Stasiak, K., Dunowska, M., & Rola, J. (2020) · BMC Veterinary Research · doi:10.1186/s12917-020-02586-y · Cited by 21
Antiherpetic Drugs in Equine Medicine
Maxwell, L. K. (2017) · Veterinary Clinics of North America Equine Practice · doi:10.1016/j.cveq.2016.12.002 · Cited by 19
El-Hage, C. M., Mekuria, Z. H., Dynon, K., Hartley, C. A., McBride, K. L., & Gilkerson, J. R. (2021) · Animals · doi:10.3390/ani11123418 · Cited by 19
Giessler, K. S., Goehring, L. S., Jacob, S. I., Davis, A., Esser, M. M., Lee, Y., Zarski, L. M., Weber, P. S. D., & Hussey, G. S. (2024) · Journal of General Virology · doi:10.1099/jgv.0.001987 · Cited by 18
Slater, J. D. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-0891-8.00014-2 · Cited by 36
Self-citationDendritic cells presenting equine herpesvirus-1 antigens induce protective anti-viral immunity.
Steinbach, F., Stingl, G., Elbe-B√orger, A., Borchers, K., Ludwig, H., & Ricciardi‐Castagnoli, P. (1998) · Journal of General Virology · doi:10.1099/0022-1317-79-12-3005 · Cited by 18
(AHAW), E. P. O. A. H. A. W., Nielsen, S. S., Álvarez, J., Bicout, D., Calistri, P., Canali, E., Drewe, J. A., Garin‐Bastuji, B., Gonzáles, J. L., Gortázar, C., et al. (2022) · EFSA Journal · doi:10.2903/j.efsa.2022.7036 · Cited by 20
Marenzoni, M. L., Passamonti, F., Cappelli, K., Veronesi, F., Capomaccio, S., Supplizi, A. V., Valente, C., Autorino, G. L., & Coletti, M. (2008) · Veterinary Record · doi:10.1136/vr.162.11.337 · Cited by 17
“The viral strains infecting all the foals were the same and they were kept under the same conditions.”
BackgroundGiessler, K. S., Samoilowa, S., Soboll Hussey, G., Kiupel, M., Matiasek, K., Sledge, D. G., Liesche, F., Schlegel, J., Fux, R., & Goehring, L. S. (2020) · Frontiers in Veterinary Science · doi:10.3389/fvets.2020.00621 · Cited by 16
Mechanisms of Disease and Immunity
Mealey, R. H., & Long, M. T. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-44329-6.00001-2 · Cited by 17
Hussey, G. S., & Giessler, K. S. (2022) · The Veterinary Journal · doi:10.1016/j.tvjl.2022.105827 · Cited by 16
Ata, E. B., Zaghawa, A. A., Ghazy, A. A., Elsify, A. M., & Shaapan, R. M. (2017) · Asian Journal of Epidemiology · doi:10.3923/aje.2018.34.45 · Cited by 18
Ko, S., Kang, J., Yeh, J., Moon, J., Choi, G.-C., Won, S., & Chae, J. (2013) · Journal of Equine Veterinary Science · doi:10.1016/j.jevs.2012.11.001 · Cited by 15
Detection and genotyping of equid herpesvirus 1 in Uruguay
CASTRO, E. R., & Arbiza, J. (2017) · Scientific and Technical Review (World Organisation for Animal Health) · doi:10.20506/rst.36.3.2715 · Cited by 14
Awan, A. R., & Field, H. J. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.11.2478 · Cited by 14
Self-citationde Carvalho, R. F., Passos, L. M. F., Oliveira, A. M., Henry, M., & Martins, A. S. (2000) · Arquivo Brasileiro de Medicina Veterinária e Zootecnia · doi:10.1590/s0102-09352000000400002 · Cited by 14
Bażanów, B., Jackulak, N., Frącka, A., & Staroniewicz, Z. (2013) · Equine Veterinary Education · doi:10.1111/eve.12084 · Cited by 12
“Pathogenesis The upper respiratory tract is the natural gateway of entry for EHV-1 and -4 and the respiratory mucosal epithelium is the main target for infection (Allen and Bryans 1986; Gibson et al. 1992; Allen et al. 2004).”
BackgroundReed, S. M., Bayly, W. M., & Sellon, D. C. (2004) · Elsevier eBooks · doi:10.1016/b0-72-169777-1/50003-2 · Cited by 11
Infectious diseases of the respiratory system
Finley, M. (2007) · Elsevier eBooks · doi:10.1016/b978-070202823-6.50134-2 · Cited by 11
Equine herpesvirus neurological disease
Gilkerson, J. R. (2008) · Equine Veterinary Journal · doi:10.2746/042516408x284457 · Cited by 10
Pusterla, N., Dorman, D. C., Burgess, B. A., Goehring, L. S., Gross, M., Osterrieder, N., Hussey, G. S., & Lunn, D. P. (2023) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.16958 · Cited by 9
Ahdy, A. M., Ahmed, B. M., Elgamal, M. A., Shaalan, M., Farag, I. M., Mahfouz, E. R., Darwish, H. R. H., Sayed-Ahmed, M. Z., Shalaby, M. A., & El-Sanousi, A. A. (2022) · Journal of Equine Veterinary Science · doi:10.1016/j.jevs.2022.103960 · Cited by 8
Respiratory and neurological disease in rabbits experimentally infected with equid herpesvirus 1
Kanitz, F. A., Cargnelutti, J. F., Anziliero, D., Gonçalves, K. V., Masuda, E. K., Weiblen, R., & Flores, E. F. (2015) · Microbial Pathogenesis · doi:10.1016/j.micpath.2015.07.007 · Cited by 8
Kydd, J. H., Hannant, D., Robinson, R. S., Bryant, N. A., & Osterrieder, N. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.09.106 · Cited by 8
“The production of specific pathogen-free foals is costly and time-consuming [32] so a pragmatic alternative to assess vaccine-induced immunity is to identify synchronized pregnant mares, unvaccinated against EHV-1, then use their offspring at weaning, when maternally-derived colostrum titres have declined, to assess v…”
BackgroundEquine Herpesvirus-1 Infection, Clinical Features, Treatment and Control
Ata, E. B., Ghazy, A. A., & Shaapan, R. M. (2020) · Advances in Animal and Veterinary Sciences · doi:10.17582/journal.aavs/2020/8.6.668.679 · Cited by 8
“An initial leukopenia followed by leukocytosis develop approximately one week following EHV-1 infection coincide with the second peak of fever, and often with the change in the character of nasal discharge (Gibson et al., 1992a).”
InfluentialMori, Ê., Mori, C. M. C., Massironi, S. M. G., Cunha, E. M. S., Villalobos, E. M. C., Lara, M. D. C. C. D. S. H., & Fernandes, W. R. (2009) · Brazilian Journal of Veterinary Research and Animal Science · doi:10.11606/issn.1678-4456.bjvras.2009.26773 · Cited by 8
Equine herpesvirus myeloencephalopathy in a 14-year-old quarter horse stallion.
Tf, O. (2001) · Europe PMC (PubMed Central) · Cited by 8
Swerczek, T. W., & Dennis, S. M. (2007) · Elsevier eBooks · doi:10.1016/b978-072169323-1.50025-8 · Cited by 20
Epidemiology of EHV-1 and EHV-4 infections: A review
Saïd, D. (2021) · International Journal of Veterinary Science and Research · doi:10.17352/ijvsr.000088 · Cited by 7
“Clinical disease may result from this recrudescence [15].”
Sáenz, J. R., Góez, Y., & Herrera, A. L. (2009) · Revista Colombiana de Ciencias Pecuarias · doi:10.17533/udea.rccp.324308 · Cited by 7
Rybachuk, G. V. (2008) · Louisiana State University · doi:10.31390/gradschool_dissertations.2545 · Cited by 8
“For 9–14 days starting from 4–6 days post EHV-1 infection, an extensive cell-associated viremia is detectable (Gibson et al., 1992).”
BackgroundViremia in Equine Herpes Virus-1 infection and a possible link to Transient Protective Immunity
Awan, A. R., Tulp, O., & Field, H. J. (2021) · Journal of Human Virology & Retrovirology · doi:10.15406/jhvrv.2021.09.00238 · Cited by 4
Self-citationWang, L. (2003) · Murdoch University Research Portal · Cited by 8
The Equine Virology Research Foundation ‐ a view from abroad
Allen, G. P. (1994) · Equine Veterinary Journal · doi:10.1111/j.2042-3306.1994.tb04385.x · Cited by 5
Sequence analysis of thymidine kinase-defective mutants of equine herpesvirus-1 (EHV-1)
Corrochano, L. M., Madueño, F., Field, H. J., & de la Fuente, R. (1993) · Gene · doi:10.1016/0378-1119(93)90376-e · Cited by 4
Self-citationAntimicrobial prescribing guidelines for horses in Australia
Hardefeldt, L. Y., Thomas, K., Page, S. W., Norris, J. M., Browning, G. F., Hage, C. E., Stewart, A. J., Gilkerson, J. R., Muscatello, G., Verwilghen, D., et al. (2025) · Australian Veterinary Journal · doi:10.1111/avj.70003 · Cited by 3
Wong, D., Wilkins, P. A., & Landolt, G. A. (2024) · Wiley eBooks · doi:10.1002/9781119617228.ch50 · Cited by 3
Latent equine herpesvirus infections in horses
Hamzah, H. B. (2008) · Murdoch University Research Portal · Cited by 2
Equine Herpes Virus-1. A clinician’s perspective.
Tyrnenopoulou, P., & Diakakis, N. E. (2023) · Journal of the Hellenic Veterinary Medical Society · doi:10.12681/jhvms.29907 · Cited by 1
Respiratory pathogens in thoroughbred foals up to one year of age on a stud farm in South Africa
Picard, J.-L. (2007) · UpSpace Institutional Repository (University of Pretoria) · Cited by 1
Kazachka, D., Chenchev, I., & Martinov, S. P. (1997) · Biotechnology & Biotechnological Equipment · doi:10.1080/13102818.1997.10818920 · Cited by 1
Another fence jumped in the EHV‐1 stakes
Edington, N. (1994) · Equine Veterinary Journal · doi:10.1111/j.2042-3306.1994.tb04046.x · Cited by 1
Interaction of equine herpesvirus 1 with equine peripheral blood mononuclear cells
van der Meulen, K. (2003) · Ghent University Academic Bibliography (Ghent University) · Cited by 3
Smith, K. L. (2013) · UKnowledge (University of Kentucky) · Cited by 1
Detection and Differentiation of Equine Herpes Virus Type 1 and Type 4 on the LightCycler
Hübert, P. H. (2001) · Springer eBooks · doi:10.1007/978-3-642-59524-0_38
Virala orsaker till abort hos hund
Salomonsson, S. (2010) · Epsilon Archive for Student Projects (Swedish University of Agricultural Sciences)
Fritsche, A.-K. (2015) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-15596
Böttner, D. (2010) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-14280
Marzo, A. D. (2013) · University Library - University of Saskatchewan (University of Saskatchewan)
Metadata
- Authors
- Gibson, J. S., Slater, J. D., Awan, A. R., & Field, H. J.
- Affiliations
- University of Cambridge (GB)
- Venue
- Archives of Virology
- Published
- 1992-09
- Volume
- 123
- Issue
- 3-4
- Pages
- 351-366
- ISSN
- 0003-9012 (ISSN-L)
- 0304-8608
- 1432-8798
- OpenAlex
- W2024212171
- Cited by
- 114
- References
- 20
- Citations by year
- 2025: 2 · 2024: 2 · 2023: 2 · 2022: 5 · 2021: 6 · 2020: 3 · 2019: 4 · 2018: 2 · 2017: 6 · 2016: 1 · 2015: 4 · 2014: 3 · 2013: 6 · 2012: 1
- FWCI
- 5.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Archives of Virology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Herpesvirus Infections and Treatments
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Keywords
- equine herpesvirus 1, equine herpesvirus 4, pathogenesis, foals, primary infection, secondary infection, viral reactivation, latent infection, upper respiratory tract infection, leukopenia, lymphopenia, neutropenia, viremia, dexamethasone, intranasal inoculation
- MeSH terms
- Animals, Body Temperature, Dexamethasone, Herpesvirus 1, Equid, Female, Fluorescent Antibody Technique, Hematologic Tests, Herpesviridae Infections, Horse Diseases, Horses, Immunity, Active, Male, Neutralization Tests, Specific Pathogen-Free Organisms, Virus Activation, Virus Replication, Culture Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.